BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koh DM, Chau I, Tait D, Wotherspoon A, Cunningham D, Brown G. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2008;71:456-461. [PMID: 18164860 DOI: 10.1016/j.ijrobp.2007.10.016] [Cited by in Crossref: 98] [Cited by in F6Publishing: 74] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Gourtsoyianni S, Goh V. MRI of anal cancer: assessing response to definitive chemoradiotherapy. Abdom Imaging. 2014;39:2-17. [PMID: 24072381 DOI: 10.1007/s00261-013-0032-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
2 Barbaro B, Vitale R, Leccisotti L, Vecchio FM, Santoro L, Valentini V, Coco C, Pacelli F, Crucitti A, Persiani R. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics. 2010;30:699-716. [PMID: 20462989 DOI: 10.1148/rg.303095085] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
3 Le M, Nelson R, Lee W, Mailey B, Duldulao M, Chen Y, Garcia-aguilar J, Kim J. Evaluation of Lymphadenectomy in Patients Receiving Neoadjuvant Radiotherapy for Rectal Adenocarcinoma. Ann Surg Oncol 2012;19:3713-8. [DOI: 10.1245/s10434-012-2430-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
4 Herrmann KA, Paspulati RM, Lauenstein T, Reiser MF. Benefits and Challenges in Bowel MR Imaging at 3.0 T. Topics in Magnetic Resonance Imaging 2010;21:165-75. [DOI: 10.1097/rmr.0b013e31822a3294] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Hohenberger W, Lahmer G, Fietkau R, Croner RS, Merkel S, Göhl J, Sauer R. [Neoadjuvant radiochemotherapy for rectal cancer]. Chirurg 2009;80:294-302. [PMID: 19350306 DOI: 10.1007/s00104-009-1707-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Memon S, Lynch AC, Bressel M, Wise AG, Heriot AG. Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy. Colorectal Dis. 2015;17:748-761. [PMID: 25891148 DOI: 10.1111/codi.12976] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
7 Hunter C, Brown G. Pre-operative staging of rectal cancer: a review of imaging techniques. Expert Review of Gastroenterology & Hepatology 2016;10:1011-25. [DOI: 10.1080/17474124.2016.1179577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Lambregts DM, Beets GL, Maas M, Kessels AG, Bakers FC, Cappendijk VC, Engelen SM, Lahaye MJ, de Bruïne AP, Lammering G. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg. 2011;253:539-545. [PMID: 21239980 DOI: 10.1097/sla.0b013e31820b01f1] [Cited by in Crossref: 108] [Cited by in F6Publishing: 34] [Article Influence: 10.8] [Reference Citation Analysis]
9 Brown PJ, Hyland R, Quyn AJ, West NP, Sebag-Montefiore D, Jayne D, Sagar P, Tolan DJ. Current concepts in imaging for local staging of advanced rectal cancer. Clin Radiol 2019;74:623-36. [PMID: 31036310 DOI: 10.1016/j.crad.2019.03.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Wang H, Safar B, Wexner SD, Denoya P, Berho M. The Clinical Significance of Fat Clearance Lymph Node Harvest for Invasive Rectal Adenocarcinoma Following Neoadjuvant Therapy. Diseases of the Colon & Rectum 2009;52:1767-73. [DOI: 10.1007/dcr.0b013e3181b14eaf] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
11 Sprenger T, Rothe H, Beissbarth T, Conradi LC, Kauffels A, Homayounfar K, Behnes CL, Rödel C, Liersch T, Ghadimi M. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?]. Chirurg 2016;87:593-601. [PMID: 27106241 DOI: 10.1007/s00104-016-0170-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Cianci R, Cristel G, Agostini A, Ambrosini R, Calistri L, Petralia G, Colagrande S. MRI for Rectal Cancer Primary Staging and Restaging After Neoadjuvant Chemoradiation Therapy: How to Do It During Daily Clinical Practice. Eur J Radiol 2020;131:109238. [PMID: 32905955 DOI: 10.1016/j.ejrad.2020.109238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology. 2013;269:101-112. [PMID: 23801777 DOI: 10.1148/radiol.13122833] [Cited by in Crossref: 212] [Cited by in F6Publishing: 177] [Article Influence: 26.5] [Reference Citation Analysis]
14 Sprenger T, Rothe H, Langer C, Becker H, Liersch T. Comment on "lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival". Am J Surg Pathol 2009;33:1107; author reply 1108. [PMID: 19390426 DOI: 10.1097/PAS.0b013e31819ca2a4] [Reference Citation Analysis]
15 Kalisz KR, Enzerra MD, Paspulati RM. MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy.Radiographics. 2019;39:538-556. [PMID: 30844347 DOI: 10.1148/rg.2019180075] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
16 Cui C, Cai H, Liu L, Li L, Tian H, Li L. Quantitative analysis and prediction of regional lymph node status in rectal cancer based on computed tomography imaging. Eur Radiol. 2011;21:2318-2325. [PMID: 21713526 DOI: 10.1007/s00330-011-2182-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
17 Scabini S, Ferrando V. Number of lymph nodes after neoadjuvant therapy for rectal cancer: How many are needed? World J Gastrointest Surg 2012; 4(2): 32-35 [PMID: 22408716 DOI: 10.4240/wjgs.v4.i2.32] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
18 Heijnen LA, Lambregts DM, Lahaye MJ, Martens MH, van Nijnatten TJ, Rao SX, Riedl RG, Buijsen J, Maas M, Beets GL, Beets-Tan RG. Good and complete responding locally advanced rectal tumors after chemoradiotherapy: where are the residual positive nodes located on restaging MRI? Abdom Radiol (NY). 2016;41:1245-1252. [PMID: 26814499 DOI: 10.1007/s00261-016-0640-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
19 Habr-Gama A, Perez R, Proscurshim I, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am. 2010;19:829-845. [PMID: 20883957 DOI: 10.1016/j.soc.2010.08.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
20 Jalil O, Afaq A, Ganeshan B, Patel UB, Boone D, Endozo R, Groves A, Sizer B, Arulampalam T. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Dis 2017;19:349-62. [DOI: 10.1111/codi.13496] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
21 Li Q, Zhuo C, Cai G, Li D, Liang L, Cai S. Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy. Oncotarget 2014;5:12459-71. [PMID: 25514596 DOI: 10.18632/oncotarget.2560] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
22 Kim I, Kang J, Lim BJ, Sohn S, Lee KY. The impact of lymph node size to predict nodal metastasis in patients with rectal cancer after preoperative chemoradiotherapy. Int J Colorectal Dis 2015;30:459-64. [DOI: 10.1007/s00384-014-2099-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Sprenger T, Rothe H, Conradi LC, Beissbarth T, Kauffels A, Kitz J, Homayounfar K, Wolff H, Ströbel P, Ghadimi M, Wittekind C, Sauer R, Rödel C, Liersch T. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. Dis Colon Rectum 2016;59:377-85. [PMID: 27050599 DOI: 10.1097/DCR.0000000000000570] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
24 Sassen S, de Booij M, Sosef M, Berendsen R, Lammering G, Clarijs R, Bakker M, Beets-Tan R, Warmerdam F, Vliegen R. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur Radiol 2013;23:3440-9. [PMID: 23832319 DOI: 10.1007/s00330-013-2956-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
25 Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Bruïne AP, Kwee HW, van Engelshoven JM, van de Velde CJ, Beets-Tan RG. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology 2009;252:81-91. [PMID: 19403848 DOI: 10.1148/radiol.2521081364] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
26 McMahon CJ, Smith MP. Magnetic resonance imaging in locoregional staging of rectal adenocarcinoma. Semin Ultrasound CT MR 2008;29:433-53. [PMID: 19166041 DOI: 10.1053/j.sult.2008.10.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Liang TY, Anil G, Ang BW. Imaging paradigms in assessment of rectal carcinoma: loco-regional and distant staging. Cancer Imaging. 2012;12:290-303. [PMID: 23033451 DOI: 10.1102/1470-7330.2012.0034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
28 de Jong EA, ten Berge JC, Dwarkasing RS, Rijkers AP, van Eijck CH. The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: A metaanalysis. Surgery. 2016;159:688-699. [PMID: 26619929 DOI: 10.1016/j.surg.2015.10.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
29 Kim IK, Lim BJ, Kang J, Kim SA, Kang D, Sohn SK, Lee KY. Clinical impact of fat clearing technique in nodal staging of rectal cancer after preoperative chemoradiotherapy. J Korean Surg Soc 2013;85:30-4. [PMID: 23833758 DOI: 10.4174/jkss.2013.85.1.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
30 Gourtsoyianni S, Papanikolaou N. Role of Magnetic Resonance Imaging in Primary Rectal Cancer-Standard Protocol and Beyond. Semin Ultrasound CT MR 2016;37:323-30. [PMID: 27342896 DOI: 10.1053/j.sult.2016.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
31 Nagtegaal ID, Marijnen CAM. The future of TNM staging in rectal cancer: The era of neoadjuvant therapy. Curr colorectal cancer rep 2008;4:147-54. [DOI: 10.1007/s11888-008-0024-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kim AY. Imaging Diagnosis of Locally Advanced Rectal Cancer: Tumor Staging before and after Preoperative Chemoradiotherapy. Korean J Gastroenterol 2013;61:3. [DOI: 10.4166/kjg.2013.61.1.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 van Heeswijk MM, Lambregts DM, Palm WM, Hendriks BM, Maas M, Beets GL, Beets-Tan RG. DWI for Assessment of Rectal Cancer Nodes After Chemoradiotherapy: Is the Absence of Nodes at DWI Proof of a Negative Nodal Status? AJR Am J Roentgenol. 2017;208:W79-W84. [PMID: 27959622 DOI: 10.2214/ajr.16.17117] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 7.2] [Reference Citation Analysis]
34 Nagtegaal ID, Glynne-Jones R. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treat Rev 2020;84:101964. [PMID: 32000055 DOI: 10.1016/j.ctrv.2020.101964] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
35 van de Velde CJ, Boelens PG, Borras JM, Coebergh J, Cervantes A, Blomqvist L, Beets-tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B, Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-booth J, Meldolesi E, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA, Aristei C, Valentini V. EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum. European Journal of Cancer 2014;50:1.e1-1.e34. [DOI: 10.1016/j.ejca.2013.06.048] [Cited by in Crossref: 228] [Cited by in F6Publishing: 217] [Article Influence: 32.6] [Reference Citation Analysis]
36 Kim SH, Ryu KH, Yoon JH, Lee Y, Paik JH, Kim SJ, Jung HK, Lee KH. Apparent diffusion coefficient for lymph node characterization after chemoradiation therapy for locally advanced rectal cancer. Acta Radiol 2015;56:1446-53. [PMID: 25425724 DOI: 10.1177/0284185114560936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
37 Alberda WJ, Dassen HPN, Dwarkasing RS, Willemssen FEJA, van der Pool AEM, de Wilt JHW, Burger JWA, Verhoef C. Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2013;28:573-80. [DOI: 10.1007/s00384-012-1576-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
38 Lambregts DM, Beets-Tan RG. Optimal imaging staging of rectal cancer. EJC Suppl 2013;11:38-44. [PMID: 26217112 DOI: 10.1016/j.ejcsup.2013.07.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
39 Yan H, Wang R, Zhu K, Zhao W, Jiang S, Feng R, Xu X, Meng X, Sun H, Zhang H, Mu D, Xu Z. Predictors of Sensitivity to Preoperative Chemoradiotherapy of Rectal Adenocarcinoma. Tumori 2011;97:717-23. [DOI: 10.1177/030089161109700607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
40 Balyasnikova S, Brown G. Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management. Curr Treat Options Oncol. 2016;17:32. [PMID: 27255100 DOI: 10.1007/s11864-016-0403-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
41 Dresen RC, Beets GL, Rutten HJ, Engelen SM, Lahaye MJ, Vliegen RF, de Bruïne AP, Kessels AG, Lammering G, Beets-Tan RG. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 2009;252:71-80. [PMID: 19403847 DOI: 10.1148/radiol.2521081200] [Cited by in Crossref: 112] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
42 Torok JA, Palta M, Willett CG, Czito BG. Nonoperative management of rectal cancer: NOM of Rectal Cancer. Cancer 2016;122:34-41. [DOI: 10.1002/cncr.29735] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
43 Heijnen LA, Maas M, Beets-Tan RG, Berkhof M, Lambregts DM, Nelemans PJ, Riedl R, Beets GL. Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging? Int J Colorectal Dis. 2016;31:1157-1162. [PMID: 27055660 DOI: 10.1007/s00384-016-2576-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
44 Lambregts DM, Maas M, Riedl RG, Bakers FC, Verwoerd JL, Kessels AG, Lammering G, Boetes C, Beets GL, Beets-Tan RG. Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study. Eur Radiol. 2011;21:265-273. [PMID: 20730540 DOI: 10.1007/s00330-010-1937-x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 76] [Article Influence: 8.2] [Reference Citation Analysis]
45 Gehoff A, Basten O, Sprenger T, Conradi LC, Bismarck C, Bandorski D, Merkelbach-Bruse S, Schneider-Stock R, Stoehr R, Wirtz RM. Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method. Am J Surg Pathol. 2012;36:202-213. [PMID: 22251939 DOI: 10.1097/pas.0b013e31823fa35b] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
46 Boysen AK, Wettergren Y, Sorensen BS, Taflin H, Gustavson B, Spindler KG. Cell-free DNA levels and correlation to stage and outcome following treatment of locally advanced rectal cancer. Tumour Biol 2017;39:101042831773097. [DOI: 10.1177/1010428317730976] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
47 Sprenger T, Rothe H, Homayounfar K, Beissbarth T, Ghadimi BM, Becker H, Liersch T. Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up. J Gastrointest Surg 2010;14:96-103. [PMID: 19830503 DOI: 10.1007/s11605-009-1057-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
48 Dinaux AM, Leijssen L, Bordeianou LG, Kunitake H, Amri R, Berger DL. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer. Surgery 2018;163:784-8. [PMID: 29277386 DOI: 10.1016/j.surg.2017.10.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
49 Sprenger T, Rothe H, Becker H, Beissbarth T, Homayounfar K, Gauss K, Kitz J, Wolff H, Scheel AH, Ghadimi M, Rödel C, Conradi L, Liersch T. Lymph Node Metastases in Rectal Cancer After Preoperative Radiochemotherapy: Impact of Intramesorectal Distribution and Residual Micrometastatic Involvement. American Journal of Surgical Pathology 2013;37:1283-9. [DOI: 10.1097/pas.0b013e3182886ced] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
50 Maffione AM, Montesi G, Caroli P, Colletti PM, Rubello D, Matteucci F. Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?Clin Nucl Med. 2020;45:611-617. [PMID: 32558716 DOI: 10.1097/RLU.0000000000003132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Lopez-Lopez V, Abrisqueta J, Lujan J, Hernandez Q, Ono A, Parrilla P. Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer. Saudi J Gastroenterol 2016;22:148-53. [PMID: 26997222 DOI: 10.4103/1319-3767.178526] [Reference Citation Analysis]
52 Cravo M, Rodrigues T, Ouro S, Ferreira A, Féria L, Maio R. Management of rectal cancer: Times they are changing. GE Portuguese Journal of Gastroenterology 2014;21:192-200. [DOI: 10.1016/j.jpg.2014.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Loftås P, Sturludóttir M, Hallböök O, Almlöv K, Arbman G, Blomqvist L. Assessment of remaining tumour involved lymph nodes with MRI in patients with complete luminal response after neoadjuvant treatment of rectal cancer. Br J Radiol 2018;91:20170938. [PMID: 29668301 DOI: 10.1259/bjr.20170938] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Heo SH, Kim JW, Shin SS, Jeong YY, Kang HK. Multimodal imaging evaluation in staging of rectal cancer. World J Gastroenterol 2014; 20(15): 4244-4255 [PMID: 24764662 DOI: 10.3748/wjg.v20.i15.4244] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
55 Torkzad MR, Påhlman L, Glimelius B. Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging 2010;1:245-67. [PMID: 22347920 DOI: 10.1007/s13244-010-0037-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
56 Valentini V, Glimelius B. Rectal cancer radiotherapy: towards European consensus. Acta Oncol. 2010;49:1206-1216. [PMID: 20843179 DOI: 10.3109/0284186x.2010.506884] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
57 Beets-Tan RG, Beets GL. Local staging of rectal cancer: a review of imaging. J Magn Reson Imaging 2011;33:1012-9. [PMID: 21509856 DOI: 10.1002/jmri.22475] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
58 Yoon WS, Park W, Choi DH, Ahn YC, Chun HK, Lee WY, Yun SH, Kang WK, Lim HY, Park YS. Importance of the Circumferential Extent of Tumors and Clinical Lymph Node Status as Prognostic Factors after Preoperative Chemoradiotherapy and Surgery in Patients with Rectal Cancer. Tumori 2010;96:568-76. [DOI: 10.1177/030089161009600409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
59 Li Q, Zhuo C, Liang L, Zheng H, Li D, Cai S. Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer. Medicine (Baltimore) 2015;94:e395. [PMID: 25621683 DOI: 10.1097/MD.0000000000000395] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
60 Sclafani F, Cunningham D. Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer. Future Oncology 2014;10:2243-57. [DOI: 10.2217/fon.14.127] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
61 Evans J, Patel U, Brown G. Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol. 2011;21:169-177. [PMID: 21645861 DOI: 10.1016/j.semradonc.2011.02.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
62 Langman G, Patel A, Bowley DM. Size and distribution of lymph nodes in rectal cancer resection specimens. Dis Colon Rectum 2015;58:406-14. [PMID: 25751797 DOI: 10.1097/DCR.0000000000000321] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
63 Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P, Quirke P, Sebag-Montefiore D, Moran B, Heald R. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29:3753-3760. [PMID: 21876084 DOI: 10.1200/jco.2011.34.9068] [Cited by in Crossref: 375] [Cited by in F6Publishing: 142] [Article Influence: 37.5] [Reference Citation Analysis]
64 Smith FM, Waldron D, Winter DC. Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg. 2010;97:1752-1764. [PMID: 20845400 DOI: 10.1002/bjs.7251] [Cited by in Crossref: 112] [Cited by in F6Publishing: 95] [Article Influence: 10.2] [Reference Citation Analysis]
65 Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"? Radiology 2013;268:330-44. [PMID: 23882096 DOI: 10.1148/radiol.13121361] [Cited by in Crossref: 143] [Cited by in F6Publishing: 117] [Article Influence: 17.9] [Reference Citation Analysis]
66 Han J, Noh GT, Yeo SA, Cheong C, Cho MS, Hur H, Min BS, Lee KY, Kim NK. The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer. Medicine95:e4891. [PMID: 27661032 DOI: 10.1097/md.0000000000004891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Dedemadi G, Wexner SD. Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate? Dig Dis. 2012;30 Suppl 2:109-117. [PMID: 23207942 DOI: 10.1159/000342039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
68 Roxburgh CSD, Strombom P, Lynn P, Cercek A, Gonen M, Smith JJ, Temple LKF, Nash GM, Guillem JG, Paty PB, Shia J, Vakiani E, Yaeger R, Stadler ZK, Segal NH, Reidy D, Varghese A, Wu AJ, Crane CH, Gollub MJ, Saltz LB, Garcia-Aguilar J, Weiser MR. Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short-term outcomes. Colorectal Dis 2019;21:1140-50. [PMID: 31108012 DOI: 10.1111/codi.14713] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
69 Ryu KH, Kim SH, Yoon JH, Lee Y, Paik JH, Lim YJ, Lee KH. Diffusion-weighted imaging for evaluating lymph node eradication after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. Acta Radiol. 2016;57:133-141. [PMID: 25638800 DOI: 10.1177/0284185114568908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
70 Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, Haustermans K, Maingon P, Overgaard J, Pahlman L. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol. 2009;92:148-163. [PMID: 19595467 DOI: 10.1016/j.radonc.2009.06.027] [Cited by in Crossref: 218] [Cited by in F6Publishing: 184] [Article Influence: 18.2] [Reference Citation Analysis]
71 Karpitschka M. [Rectal cancer - local staging and imaging under neoadjuvant therapy]. Radiologe 2012;52:519-28. [PMID: 22618624 DOI: 10.1007/s00117-011-2283-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Seo N, Kim H, Cho MS, Lim JS. Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences. Korean J Radiol 2019;20:1003-18. [PMID: 31270972 DOI: 10.3348/kjr.2018.0611] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
73 MERCURY Study Group. Shihab OC, Taylor F, Bees N, Blake H, Jeyadevan N, Bleehen R, Blomqvist L, Creagh M, George C, Guthrie A, Massouh H, Peppercorn D, Moran BJ, Heald RJ, Quirke P, Tekkis P, Brown G. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg. 2011;98:1798-1804. [PMID: 21928408 DOI: 10.1002/bjs.7662] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 7.9] [Reference Citation Analysis]
74 Patel UB, Blomqvist LK, Taylor F, George C, Guthrie A, Bees N, Brown G. MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience. AJR Am J Roentgenol. 2012;199:W486-W495. [PMID: 22997398 DOI: 10.2214/ajr.11.8210] [Cited by in Crossref: 107] [Cited by in F6Publishing: 37] [Article Influence: 11.9] [Reference Citation Analysis]